z-logo
open-access-imgOpen Access
Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
Author(s) -
Ogata Takatsugu,
Narita Yukiya,
Misawa Kazunari,
Hosoda Waki,
Muro Kei
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3399
Subject(s) - medicine , nivolumab , microsatellite instability , cancer , gastroenterology , oncology , immunotherapy , microsatellite , allele , gene , biochemistry , chemistry
Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI‐H tumor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here